The US government could approve MDMA for treatment purposes by 2021

A major new study could make MDMA a government-approved drug by 2021, two decades since the untimely death of activist Nicholas Saunders.

Saunders was a prominent member of the UK’s counterculture scene from the 1970s until a fatal car crash in South Africa in 1998. In the final years of his life, he dedicated himself to providing people with accurate data on drugs, particularly MDMA.

One of the main goals for his life was to make the information available to everyone. He was one of the first to tell the public details of drug testing from festivals and clubs through the website. And you must have heard of his book "E is for Ecstasy", where he dealt with anecdotal evidence on MDMA, which was one of the most integral resources of that time.

Two decades after his death, MDMA is a divisive subject in the UK, but its legitimacy as a therapeutic drug in the U.S. is just a couple of years away, thanks to the Multidisciplinary Association for Psychedelic Studies (MAPS), whose founder Rick Doblin helped bring E is for Ecstasy to America. If the final stage of their research goes well, MDMA will be an FDA-approved treatment for PTSD by 2021.